Nektar Therapeutics (NKTR) EPS (Basic) (2011 - 2026)
Nektar Therapeutics (NKTR) posted quarterly EPS (Basic) of -$1.74 for Q1 2026, up 47.15% year-over-year from -$1.19 in Q1 2025, and down 7525.04% quarter-over-quarter from -$0.02 in Q4 2025.
Powered by 
Analysis
Nektar Therapeutics (NKTR) EPS (Basic) (2011 - 2026) Analysis & Trends
Nektar Therapeutics' EPS (Basic) history runs 17 years deep, the most recent figure standing at -$1.74 for Q1 2026.
- In Q1 2026, EPS (Basic) rose 47.15% year-over-year to -$1.74; the TTM figure through Mar 2026 stood at -$4.76 (up 35.51% YoY), while the FY2025 annual figure was -$7.17, down 4.43% from the prior year.
- EPS (Basic) for Q1 2026 stood at -$1.74, down from -$0.02 in the prior quarter.
- The five-year high for EPS (Basic) was $2.34 in Q4 2024, with the low at -$12.77 in Q2 2022.
- The 5-year median for EPS (Basic) is -$3.3 (2025), against an average of -$3.63.
- The sharpest annual moves came in 2023 and 2024: EPS (Basic) plunged 305.44% in 2023, then soared 170.38% in 2024.
- Nektar Therapeutics' EPS (Basic) stood at $1.62 in 2022, then slumped by 305.44% to -$3.32 in 2023, then jumped by 170.38% to $2.34 in 2024, then tumbled by 100.98% to -$0.02 in 2025, then slumped by 7525.04% to -$1.74 in 2026.
- Business Quant data shows NKTR's EPS (Basic) at -$1.74 in Q1 2026, -$0.02 in Q4 2025, and -$1.85 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.27 Bn | 131.42 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.55 Bn | 77.56 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 63.45 Bn | 58.27 Bn | 1.37 Bn | 7.70 |
| 4 | Moderna | 57.73 Bn | 52.59 Bn | 52.00 Mn | -1.96 |
| 5 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - | -3.06 |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn | 2.12 |
| 7 | Alnylam Pharmaceuticals | 35.14 Bn | 31.84 Bn | 992.69 Mn | 1.23 |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | 0.18 |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn | -0.06 |
| 10 | Nektar Therapeutics | 2.45 Bn | 1.76 Bn | 3.04 Mn | -1.22 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.22 |
| Mar 31, 2026 | -1.74 |
| Dec 31, 2025 | -0.02 |
| Sep 30, 2025 | -1.85 |
| Jun 30, 2025 | -2.78 |
| Mar 31, 2025 | -3.30 |
| Dec 31, 2024 | 2.34 |
| Sep 30, 2024 | -2.66 |
| Jun 30, 2024 | -3.76 |
| Mar 31, 2024 | -2.83 |
| Dec 31, 2023 | 1.24 |
| Sep 30, 2023 | -3.61 |
| Jun 30, 2023 | -4.04 |
| Mar 31, 2023 | -10.88 |
| Dec 31, 2022 | 1.06 |
| Sep 30, 2022 | -4.72 |
| Jun 30, 2022 | -12.77 |
| Mar 31, 2022 | -7.30 |
| Dec 31, 2021 | -2.98 |
| Sep 30, 2021 | -10.57 |